Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6966-6972

  Palumbo, Joseph S ^a   Potter, Jill M ^a   Kaplan, Lisa S ^a   Talmage, Kathryn ^a   Jackson, David G ^b   Degen, Jay L ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; FEMALE; FIBRINOGEN DEFECT; GENOTYPE; HISTOPATHOLOGY; LEWIS CARCINOMA; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STROMA; TUMOR GROWTH;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIVISION; FIBRINOGEN; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS;

EID: 0036894405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gordon, S. G., and Mielicki, W. P. Cancer procoagulant: A factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul. Fibrinolysis, 8: 73-86, 1997.
2. Ruf, W., Fischer, E. G., Huang, H. Y., Miyagi, Y., Ott, I., Riewald, M., and Mueller, B. M. Diverse functions of protease receptor tissue factor in inflammation and metastasis. Immunol. Res., 21: 289-292, 2000.
3. Palumbo, J. S., and Degen, J. L. Hemostatic factors in tumor biology. J. Pediatr. Hematol. Oncol., 22: 281-287, 2000.
4. Dano, K., Romer, J., Nielsen, B. S., Bjorn, S., Pyke, C., Rygaard, J., and Lund, L. R. Cancer invasion and tissue remodeling: Cooperation of protease systems and cell types. APMIS, 107: 120-127, 1999.
5. Pyke, C., Kristensen, P., Ralfkiaer, E., Grondahl-Hansen, J., Eriksen, J., Blasi, F., and Dano, K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol., 138: 1059-1067, 1991.
6. Brown, L. F., Asch, B., Harvey, V. S., Buchinski, B., and Dvorak, H. F. Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. Cancer Res., 48: 1920-1925, 1988.
7. Dvorak, H. F., Nagy, J. A., Berse, B., Brown, L. F., Yeo, K. T., Yeo, T. K., Dvorak, A. M., van de Water, L., Sioussat, T. M., and Senger, D. R. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N. Y. Acad. Sci., 667: 101-111, 1992.
8. Dvorak, H. F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 315: 1650-1659, 1986.
9. Holmback, K., Danton, M. J., Suh, T. T., Daugherty, C. C., and Degen, J. L. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin α IIb β3. EMBO J., 15: 5760-5771, 1996.
10. Katagiri, Y., Hiroyama, T., Akamatsu, N., Suzuki, H., Yamazaki, H., and Tanoue, K. Involvement of α v β 3 integrin in mediating fibrin gel retraction. J. Biol. Chem., 270: 1755-1790, 1995.
11. Pluskota, E., and D'Souza, S. E. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur. J. Biochem., 267: 4693-4704, 2000.
12. Suehiro, K., Gailit, J., and Plow, E. F. Fibrinogen is a ligand for integrin α5β1 on endothelial cells. J. Biol. Chem., 272: 5360-5366, 1997.
13. Ugarova, T. P., Solovjov, D. A., Zhang, L., Loukinov, D. I., Yee, V. C., Medved, L. V., and Plow, E. F. Identification of a novel recognition sequence for integrin αM β2 within the γ chain of fibrinogen. J. Biol. Chem., 273: 22519-22527, 1998.
14. Smiley, S. T., King, J. A., and Hancock, W. W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol., 167: 2887-2894, 2001.
15. Languino, L. R., Duperray, A., Joganic, K. J., Fornaro, M., Thornton, G. B., and Altieri, D. C. Regulation of leukocyte-endothelium interaction and leukocyte transen- dothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc. Natl. Acad. Sci. USA, 92: 1505-1509, 1995.
16. Rubel, C., Fernandez, G. C., Rosa, F. A., Gomez, S., Bompadre, M. B., Coso, O. A., Isturiz, M. A., and Palermo, M. S. Soluble fibrinogen modulates neutrophil functionality through the activation of an extracellular signal-regulated kinase-dependent pathway. J. Immunol., 168: 3527-3535, 2002.
17. Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., McDonagh, J., and Dvorak, A. M. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Investig., 57: 673-686, 1987.
18. Thompson, W. D., Smith, E. B., Stirk, C. M., Marshall, F. I., Stout, A. J., and Kocchar, A. Angiogenic activity of fibrin degradation products is located in fibrin fragment. Eur. J. Pathol., 168: 47-53, 1992.
19. Thompson, W. D., Campbell, R., and Evans, T. Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane. J. Pathol., 145: 27-37, 1985.
20. Esumi, N., Fan, D., and Fidler, I. J. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res., 51: 4549-4556, 1991.
21. Gasic, G. J. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev., 3: 99-114, 1984.
22. Bugge, T. H., Kombrinck, K. W., Xiao, Q., Holmback, K., Daugherty, C. C., Witte, D. P., and Degen, J. L. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood., 90: 4522-4531, 1997.
23. Bugge, T. H., Lund, L. R., Kombrinck, K. K., Nielsen, B, S., Holmback, K., Drew, A. F., Flick, M. J., Witte, D. P., Dano, K., and Degen, J. L. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene. 16: 3097-3104, 1998.
24. Gutierrez, L, S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V. A., and Castellino, F. J. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-I. Cancer Res., 60: 5839-5847, 2000.
25. Bajou, K., Noel, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., and Foidart, J. M. Absence of host plasminogen activator inhibitor I prevents cancer invasion and vascularization. Nat. Med., 4: 923-925, 1998.
26. Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., and Bugge, T. H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood, 96: 3302-3309, 2000.
27. Suh, T. T., Holmback, K., Jensen, N. J., Daugherty, C. C., Small, K., Simon, D. I., Potter, S., and Degen, J. L. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev., 9: 2020-2033, 1995.
28. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M., and Jackson, D. G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol., 144: 789-801, 1999.
29. Geran, H., Greenberg, N., MacDonald, M., Schumacher, A., and Abbot, B. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep., 3: 1-16, 1972.
30. Drew, A. F., Liu, H., Davidson, J. M., Daugherty, C. C., and Degen, J. L. Wound-healing defects in mice lacking fibrinogen. Blood, 97: 3691-3698, 2001.
31. Jackson, D. G., Prevo, R., Clasper, S., and Banerji, S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol., 22: 317-321, 2001.
32. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med., 7: 186-191, 2001.
33. Brown, L. F., Lanir, N., McDonagh, J., Tognazzi, K., Dvorak, A. M., and Dvorak, H. F. Fibroblast migration in fibrin gel matrices. Am. J. Pathol., 142: 273-283, 1993.
34. Miller, G. J., Howarth, D. J., Attfield, J. C., Cooke, C. J., Nanjee, M. N., Olszewski, W. L., Morrissey, J. H., and Miller, N. E. Haemostatic factors in human peripheral afferent lymph. Thromb. Haemostasis, 83: 427-432, 2000.
35. Nieswandt, B., Hafner, M., Echtenacher, B., and Mannel, D. N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res., 59: 1295-1300, 1999.